Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pleiotropic and Adverse Effects of Statins—Do Epigenetics Play a Role?
Stephanie C. Allen, Cyril Mamotte
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 2, pp. 319-326
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu, Iqra Ilyas, Peter J. Little, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 924-967
Open Access | Times Cited: 697
Sex- and Gender-Based Pharmacological Response to Drugs
Franck Mauvais‐Jarvis, Heiner K. Berthold, Ilaria Campesi, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 730-762
Open Access | Times Cited: 137
Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 106
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Charlotte Ling, Karl Bacos, Tina Rönn
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 433-448
Closed Access | Times Cited: 78
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Suowen Xu, Danielle Kamato, Peter J. Little, et al.
Pharmacology & Therapeutics (2018) Vol. 196, pp. 15-43
Open Access | Times Cited: 139
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Andy Göbel, Martina Rauner, Lorenz C. Hofbauer, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188351-188351
Closed Access | Times Cited: 129
Simvastatin increases temozolomide‐induced cell death by targeting the fusion of autophagosomes and lysosomes
Shahla Shojaei, Navid Koleini, Ehsan Samiei, et al.
FEBS Journal (2019) Vol. 287, Iss. 5, pp. 1005-1034
Open Access | Times Cited: 117
The role of adjuvant immunomodulatory agents for treatment of severe influenza
David S.C. Hui, Nelson Lee, Paul K.S. Chan, et al.
Antiviral Research (2018) Vol. 150, pp. 202-216
Open Access | Times Cited: 96
Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial
Elizabeth Sapey, Jaimin Patel, Hannah Greenwood, et al.
American Journal of Respiratory and Critical Care Medicine (2019) Vol. 200, Iss. 10, pp. 1282-1293
Open Access | Times Cited: 93
From Mitochondria to Atherosclerosis: The Inflammation Path
Juan M. Suárez-Rivero, Carmen J. Pastor‐Maldonado, Suleva Povea-Cabello, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 258-258
Open Access | Times Cited: 57
How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span
Anne-Marie Galow, Shahaf Peleg
Cells (2022) Vol. 11, Iss. 3, pp. 468-468
Open Access | Times Cited: 44
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies
Ali Zarrabi, David Perrin, Mahboubeh Kavoosi, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5269-5269
Open Access | Times Cited: 37
Concise Review: Optimized Strategies for Stem Cell-Based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation
Rongrong Wu, Xinyang Hu, Jianan Wang
Stem Cells (2018) Vol. 36, Iss. 4, pp. 482-500
Open Access | Times Cited: 76
NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
Negin Parsamanesh, Maryam Moossavi, Afsane Bahrami, et al.
International Immunopharmacology (2019) Vol. 73, pp. 146-155
Closed Access | Times Cited: 74
Epigenetic Link Between Statin Therapy and Type 2 Diabetes
Carolina Ochoa‐Rosales, Eliana Portilla-Fernández, Jana Nano, et al.
Diabetes Care (2020) Vol. 43, Iss. 4, pp. 875-884
Open Access | Times Cited: 55
The pharmaco-epigenetics of hypertension: a focus on microRNA
Serge Yaacoub, Ammar Boudaka, Ali Alkhatib, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3255-3271
Open Access | Times Cited: 8
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
Cristina Barale, Chiara Frascaroli, Rouslan Senkeev, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-11
Open Access | Times Cited: 58
Are the Statins promising antifungal agents against invasive candidiasis?
William Gustavo Lima, Lídia Anita Alves-Nascimento, Jéssica Tauany Andrade, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 111, pp. 270-281
Open Access | Times Cited: 57
MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy
Mohammad Mohajeri, Maciej Banach, Stephen L. Atkin, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 11, pp. 967-981
Closed Access | Times Cited: 55
Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide-induced premature ovarian failure in female albino mice
M.H.R. El-Kady, Shahinaz M. Shalaby, Farzaneh Fathi, et al.
Human & Experimental Toxicology (2019) Vol. 38, Iss. 11, pp. 1283-1295
Open Access | Times Cited: 47
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases
Giuditta Benincasa, Rosa Suades, Teresa Padró, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 8, pp. 758-769
Closed Access | Times Cited: 14
Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease
Teresa Infante, Luca Del Viscovo, Maria Luisa De Rimini, et al.
Journal of Atherosclerosis and Thrombosis (2019) Vol. 27, Iss. 4, pp. 279-302
Open Access | Times Cited: 42
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154809-154809
Closed Access | Times Cited: 13
Statin‐dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content
Charleston F. Christie, Diana Fang, Elizabeth G. Hunt, et al.
The FASEB Journal (2019) Vol. 33, Iss. 7, pp. 8186-8201
Open Access | Times Cited: 35
Implication of DNA methylation during lifestyle mediated weight loss
S. Aurich, Luise Müller, Péter Kovács, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top